Kevan Shokat

Dr. Shokat is a Co-Founder of Mitokinin and the Chairman of the Company’s Scientific Advisory Board. Dr. Shokat uses synthetic organic chemistry, structural biology, and molecular modeling to develop selective chemical inhibitors and activators of key signal transduction targets. He is an internationally recognized expert on kinases and one of the pioneers in the field chemical biology. Dr. Shokat directed the research

along with Nicholas Hertz) that led to the discovery of the technology that underpins Mitokinin’s therapeutics. He is a Professor, HHMI investigator, and Vice Chair of Molecular Pharmacology at UCSF, and a Member of the National Academies of Science and Medicine. In addition to Mitokinin, Dr. Shokat has co-founded numerous successful startups, including IntelliKine, eFFECTOR, and Wellspring Biosciences.

Dr. Shokat completed his Ph.D in the laboratory of Peter Schultz at the University of California, Berkeley, earning UC Berkeley Regents and University Fellowships. He completed his postdoctoral training in the lab of Christopher Goodnow at Stanford.